Sulpiride: A weak antagonist of norepinephrine and 5-hydroxytryptamine

Jai D. Kohli, Larry Cripe

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Antagonism of norepinephrine (NE) and 5-hydroxytryptamine (5-HT) by sulpiride was studied in vitro on rabbit aortic strips. Concentrations of sulpiride ranging from 3 × 10-5 to 3 × 10-3 M caused a progressive shift of the dose response curves of both NE and 5-HT to the right without inhibiting the responses to KCl. pA2 values of sulpiride calculated from Schild plots against NE and 5-HT were 4.6 and 4.4, respectively. Thus, sulpiride, which has been previously shown to be the most potent antagonist of the dopamine vascular receptors, is a very weak α-adrenergic or 5-HT antagonist.

Original languageEnglish (US)
Pages (from-to)283-286
Number of pages4
JournalEuropean Journal of Pharmacology
Volume56
Issue number3
DOIs
StatePublished - Jun 15 1979
Externally publishedYes

Fingerprint

Sulpiride
Serotonin Antagonists
Norepinephrine
Serotonin
Dopamine Antagonists
Adrenergic Agents
Blood Vessels
Rabbits

Keywords

  • 5-HT antagonism
  • NE antagonism
  • Sulpiride

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Sulpiride : A weak antagonist of norepinephrine and 5-hydroxytryptamine. / Kohli, Jai D.; Cripe, Larry.

In: European Journal of Pharmacology, Vol. 56, No. 3, 15.06.1979, p. 283-286.

Research output: Contribution to journalArticle

@article{52a3083c3da94c40bcb9064057c2be56,
title = "Sulpiride: A weak antagonist of norepinephrine and 5-hydroxytryptamine",
abstract = "Antagonism of norepinephrine (NE) and 5-hydroxytryptamine (5-HT) by sulpiride was studied in vitro on rabbit aortic strips. Concentrations of sulpiride ranging from 3 × 10-5 to 3 × 10-3 M caused a progressive shift of the dose response curves of both NE and 5-HT to the right without inhibiting the responses to KCl. pA2 values of sulpiride calculated from Schild plots against NE and 5-HT were 4.6 and 4.4, respectively. Thus, sulpiride, which has been previously shown to be the most potent antagonist of the dopamine vascular receptors, is a very weak α-adrenergic or 5-HT antagonist.",
keywords = "5-HT antagonism, NE antagonism, Sulpiride",
author = "Kohli, {Jai D.} and Larry Cripe",
year = "1979",
month = "6",
day = "15",
doi = "10.1016/0014-2999(79)90185-7",
language = "English (US)",
volume = "56",
pages = "283--286",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Sulpiride

T2 - A weak antagonist of norepinephrine and 5-hydroxytryptamine

AU - Kohli, Jai D.

AU - Cripe, Larry

PY - 1979/6/15

Y1 - 1979/6/15

N2 - Antagonism of norepinephrine (NE) and 5-hydroxytryptamine (5-HT) by sulpiride was studied in vitro on rabbit aortic strips. Concentrations of sulpiride ranging from 3 × 10-5 to 3 × 10-3 M caused a progressive shift of the dose response curves of both NE and 5-HT to the right without inhibiting the responses to KCl. pA2 values of sulpiride calculated from Schild plots against NE and 5-HT were 4.6 and 4.4, respectively. Thus, sulpiride, which has been previously shown to be the most potent antagonist of the dopamine vascular receptors, is a very weak α-adrenergic or 5-HT antagonist.

AB - Antagonism of norepinephrine (NE) and 5-hydroxytryptamine (5-HT) by sulpiride was studied in vitro on rabbit aortic strips. Concentrations of sulpiride ranging from 3 × 10-5 to 3 × 10-3 M caused a progressive shift of the dose response curves of both NE and 5-HT to the right without inhibiting the responses to KCl. pA2 values of sulpiride calculated from Schild plots against NE and 5-HT were 4.6 and 4.4, respectively. Thus, sulpiride, which has been previously shown to be the most potent antagonist of the dopamine vascular receptors, is a very weak α-adrenergic or 5-HT antagonist.

KW - 5-HT antagonism

KW - NE antagonism

KW - Sulpiride

UR - http://www.scopus.com/inward/record.url?scp=0018399975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018399975&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(79)90185-7

DO - 10.1016/0014-2999(79)90185-7

M3 - Article

C2 - 477724

AN - SCOPUS:0018399975

VL - 56

SP - 283

EP - 286

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 3

ER -